Company Filing History:
Years Active: 2017
Title: The Innovations of Argeris N. Karabelas in Treating Schizophrenia
Introduction
Argeris N. Karabelas, based in Portsmouth, NH, is an innovative inventor recognized for his contributions to the field of neuroscience. With a focus on mental health, specifically schizophrenia, his work has paved the way for new treatment methodologies that can significantly impact patients’ lives.
Latest Patents
Dr. Karabelas holds a patent for "Methods of use of cyclic amide derivatives to treat schizophrenia." This patent details compositions and methods designed to address both the positive and negative symptoms associated with schizophrenia, marking a notable advancement in therapeutic options for this complex mental disorder.
Career Highlights
Over his career, Argeris has worked with notable companies in the pharmaceutical industry, including Minerva Neurosciences, Inc. and Cyrenaic Pharmaceuticals, Inc. His expertise in neuroscience and pharmacology has played a critical role in developing new treatments aimed at improving patient health and well-being.
Collaborations
Throughout his professional journey, Argeris has collaborated with eminent colleagues such as Remy Henri Luthringer and Lorenzo Pellegrini. These partnerships have fostered an environment of innovation, combining expertise from various facets of research to enhance the understanding and treatment of schizophrenia.
Conclusion
Argeris N. Karabelas stands out as an influential figure in the realm of neuroscience. His patented methods represent a significant leap forward in psychiatric treatment, showcasing the vital role of inventors in transforming innovative ideas into real-world applications that can improve mental health for countless individuals.